SADDAN: Difference between revisions

Jump to navigation Jump to search
No edit summary
(No difference)

Revision as of 01:11, 7 July 2009

WikiDoc Resources for SADDAN

Articles

Most recent articles on SADDAN

Most cited articles on SADDAN

Review articles on SADDAN

Articles on SADDAN in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on SADDAN

Images of SADDAN

Photos of SADDAN

Podcasts & MP3s on SADDAN

Videos on SADDAN

Evidence Based Medicine

Cochrane Collaboration on SADDAN

Bandolier on SADDAN

TRIP on SADDAN

Clinical Trials

Ongoing Trials on SADDAN at Clinical Trials.gov

Trial results on SADDAN

Clinical Trials on SADDAN at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on SADDAN

NICE Guidance on SADDAN

NHS PRODIGY Guidance

FDA on SADDAN

CDC on SADDAN

Books

Books on SADDAN

News

SADDAN in the news

Be alerted to news on SADDAN

News trends on SADDAN

Commentary

Blogs on SADDAN

Definitions

Definitions of SADDAN

Patient Resources / Community

Patient resources on SADDAN

Discussion groups on SADDAN

Patient Handouts on SADDAN

Directions to Hospitals Treating SADDAN

Risk calculators and risk factors for SADDAN

Healthcare Provider Resources

Symptoms of SADDAN

Causes & Risk Factors for SADDAN

Diagnostic studies for SADDAN

Treatment of SADDAN

Continuing Medical Education (CME)

CME Programs on SADDAN

International

SADDAN en Espanol

SADDAN en Francais

Business

SADDAN in the Marketplace

Patents on SADDAN

Experimental / Informatics

List of terms related to SADDAN

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

SADDAN (severe achondroplasia with developmental delay and acanthosis nigricans) is a rare inherited disorder of bone growth characterized by skeletal, brain, and skin abnormalities.

All people with this condition are extremely short with particularly short arms and legs. Other signs and symptoms include unusual bowing of the leg bones; a small chest with short ribs and curved collar bones; short, broad fingers; and folds of extra skin on the arms and legs. Structural abnormalities of the brain lead to seizures, profound developmental delay, and mental retardation. Acanthosis nigricans, a progressive skin disorder characterized by thick, dark, velvety skin, develops in infancy or early childhood. People with SADDAN often live into childhood and adulthood.

Many of the features of SADDAN are similar to those seen in other skeletal disorders, specifically achondroplasia and thanatophoric dysplasia.

Epidemiology

This disorder is very rare; it has been described in only a small number of individuals worldwide.

Genetics

Mutations in the FGFR3 gene cause SADDAN. The protein made by the FGFR3 gene is a receptor that plays a role in the development and maintenance of bone and brain tissue. A mutation in the gene may overactivate the receptor, which leads to disturbances in bone growth. Researchers have not determined how the mutation disrupts brain development or causes acanthosis nigricans.

SADDAN is considered an autosomal dominant disorder because one mutated copy of the FGFR3 gene in each cell is sufficient to cause the condition. The few described cases of SADDAN have been caused by new mutations in the FGFR3 gene. No individuals with this disorder are known to have had children; therefore, the disorder has not been passed to the next generation.

References

  • Bellus GA, Bamshad MJ, Przylepa KA, Dorst J, Lee RR, Hurko O, Jabs EW, Curry CJ, Wilcox WR, Lachman RS, Rimoin DL, Francomano CA (1999). "Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3". Am J Med Genet. 85 (1): 53–65. PMID 10377013.
  • Cohen MM Jr (2002). "Some chondrodysplasias with short limbs: molecular perspectives". Am J Med Genet. 112 (3): 304–13. PMID 12357475.
  • Vajo Z, Francomano CA, Wilkin DJ (2000). "The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans". Endocr Rev. 21 (1): 23–39. PMID 10696568.

External links

Template:SIB


Template:WH Template:WikiDoc Sources